Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Latest Articles

  • 4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    4DMedical Secures U.S. Deal with Intermountain Health, Unlocking Growth Path
    • News

  • Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    Race Oncology Doses First Patient in RC220 Trial, Advancing Tumour Program
    • News

  • March 2025 quarter CPI above expectations – but RBA cut still likely
    March 2025 quarter CPI above expectations – but RBA cut still likely
    • News

  • Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    Harris Technology to expand refurbished tech division amid rising demand from cost-conscious Australians
    • News

  • PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    PYC Therapeutics Moves Toward First Treatment for Blinding Childhood Eye Disease
    • News

  • Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    Impact Minerals Accelerates HPA Market Entry with Strategic HiPurA® Acquisition
    • News

  • Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    Equity Story Acquires Baker Young to Accelerate Retail Stockbroking Expansion
    • News

  • Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    Condor Confirms 3 Billion Barrel Oil Potential in Tumbes Basin
    • News

  • Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    Atomo Scales Up HIV Self-Testing Through National Vending Machine Rollout
    • News

  • Spenda Secures $3M Term Loan to Accelerate Growth
    Spenda Secures $3M Term Loan to Accelerate Growth
    • News

Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum

  • In News
  • July 24, 2024
  • Sidra Surmed
Anagenics’ signs multi-year exclusive agreement for hair regrowth tech as revenue shows momentum

Australia’s burgeoning beauty, health and wellness markets present a lucrative opportunity for businesses like Anagenics. Over the years Anagenics (ASX: AN1) have evolved from their biotech roots into a dynamic beauty, health and wellness company. In spite of economic challenges that have elicited mindful spending, Australians continue to prioritise self care, with the nation running 10th globally in wellness expenditure. 

Without a doubt, rising costs have shifted consumer behaviour – but the beauty and wellness industry has not been without its bright spots. Anagenics reported a 16% increase in revenue, totaling $10.8 million for the financial year ending June 30, 2024. 

By focusing on its core competencies and strategic partnerships, the Company has streamlined its product portfolio, aiming to facilitate working capital management and profitability. Moreover, with the early completion of royalty agreements with Advangen Japan and Roquert Therapeutics, Anagenics is exploring further opportunities to monetise their intellectual property. 

According to a survey conducted in 2023, 41% of Australians are prioritising personal care, investing an average of $431 per month on treatments like Botox, fillers, hair appointments, and nail care, with a staggering $19.7 billion spent annually.

The Company has also won a multi-year exclusive agreement with York Street Brands (YSB), which will integrate its advanced hair regrowth technology into YSB’s popular BOOST LAB and tbh Skincare brands. This collaboration will see Anagenics’ technology feature in over 2,000 Australian retail outlets. Key financial terms include upfront payments totaling $0.3 million and royalties exceeding $4.4 million over the initial 10-year term. Anagenics retains rights to its existing hair regrowth brands, ensuring strategic flexibility.

The Company achieved a $0.7 million increase in operating cash flow during the June quarter 2024 compared to pcp, reflecting an uptick in operational efficiency. Additionally, Anagenics reduced liabilities by $0.5 million since December 31 2023, maintaining a cash balance of $1.6 million as of June 30, 2024.

While the company has achieved improved cash flow and revenue growth, it anticipates significant non-cash impairment charges related to intangibles and inventory in its upcoming FY24 annual report.

AN1 shares reached a high of $0.009 in early morning trade, which was a 12.5% increase on the previous $0.008 close price.

  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  •  
  •  
  •  
  •  
  • Advangen Japan
  • Anagenics
  • asx an1
  • beauty and wellness
  • bitoech
  • Roquert Therapeutics
  • York Street Brands
  • News

Leave a Comment

You must be logged in to post a comment.

1 Comment

  • Shraddha13
    March 10, 2025, 9:05 pm

    Thank you for sharing! To explore further
    https://www.360iresearch.com/library/intelligence/hair-scalp-care-products

    Reply
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024

Login or register for free to access unlimited reading

Register Now!
  • About
  • Latest Posts
Sidra Surmed
Sidra is a Business Writer with The Sentiment
Latest posts by Sidra Surmed (see all)
  • Interest in captioning tech sees jump in earnings for AI-Media - August 29, 2024
  • Despite construction industry challenges, Duratec delivers earnings growth - August 28, 2024
  • AI-powered road safety solutions pave the way for Acusensus revenue bump - August 27, 2024
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.